These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33706839)

  • 1. Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity.
    Cho IY; Chang Y; Sung E; Kang JH; Wild SH; Byrne CD; Shin H; Ryu S
    Epidemiol Psychiatr Sci; 2021 Mar; 30():e23. PubMed ID: 33706839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis.
    Chang Y; Ryu S; Kim Y; Cho YK; Sung E; Kim HN; Ahn J; Jung HS; Yun KE; Kim S; Sung KC; Sohn CI; Shin H; Wild SH; Byrne CD
    Hepatology; 2020 Mar; 71(3):861-873. PubMed ID: 31325180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease.
    Choi IY; Chang Y; Kang G; Jung HS; Shin H; Wild SH; Byrne CD; Ryu S
    Sci Rep; 2022 Jan; 12(1):1062. PubMed ID: 35058515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study.
    Um YJ; Chang Y; Jung HS; Cho IY; Shin JH; Shin H; Wild SH; Byrne CD; Ryu S
    Clin Transl Gastroenterol; 2021 Oct; 12(10):e00417. PubMed ID: 34665792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
    Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Kim Y; Chang Y; Kwon MJ; Hong YS; Kim MK; Sohn W; Cho YK; Shin H; Wild SH; Byrne CD; Ryu S
    Am J Gastroenterol; 2021 Nov; 116(11):2270-2278. PubMed ID: 34114568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in Sleep Duration and Poor Sleep Quality over Time Is Associated with an Increased Risk of Incident Non-Alcoholic Fatty Liver Disease.
    Um YJ; Chang Y; Jung HS; Cho IY; Shin JH; Shin H; Wild SH; Byrne CD; Ryu S
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals.
    Cho IY; Chang Y; Sung E; Kang JH; Shin H; Wild SH; Byrne CD; Ryu S
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e583-e599. PubMed ID: 33930552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease.
    Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
    J Hepatol; 2020 Nov; 73(5):1023-1029. PubMed ID: 32621944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
    Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
    Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.
    Lee HH; Cho Y; Choi YJ; Huh BW; Lee BW; Kang ES; Park SW; Cha BS; Lee EJ; Lee YH; Huh KB
    Cardiovasc Diabetol; 2020 Jun; 19(1):81. PubMed ID: 32534588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
    Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
    Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
    Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population.
    Jung JY; Park SK; Oh CM; Chung PW; Ryoo JH
    J Korean Med Sci; 2019 Aug; 34(30):e199. PubMed ID: 31373184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
    Zimmermann E; Anty R; Tordjman J; Verrijken A; Gual P; Tran A; Iannelli A; Gugenheim J; Bedossa P; Francque S; Le Marchand-Brustel Y; Clement K; Van Gaal L; Sørensen TIA; Jess T
    J Hepatol; 2011 Sep; 55(3):660-665. PubMed ID: 21238518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study.
    Chang Y; Cho YK; Cho J; Jung HS; Yun KE; Ahn J; Sohn CI; Shin H; Ryu S
    Am J Gastroenterol; 2019 Apr; 114(4):620-629. PubMed ID: 30694866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.